host cell entry and mediates the fusion of the viral envelope to the The annual production of inﬂuenza vaccine through conv
late endosomal membrane. Neutralising antibodies that block HA tional, mostly egg-based platforms, is arduous and a ra
21
effectively prevent viral entry into target cells and have been against-time . The production process, from the selection
shown to protect the host from infection10,11. Another viral surface inﬂuenza strains to vaccine manufacture and release